Drug Targets and Toxicological Profiles by Gene Expression Analysis

IDENTIFICATION OF DRUG TARGETS AND TOXICOLOGICAL PROFILES BY GENE EXPRESSION ANALYSIS 

Gene Expression Analysis of Drug-Treated Cells 

We thank Karen Novik, Payal Sipahimalani, and Stephen Montgomery for their helpful comments. J.H.W. is supported by an Erwin-Schrodinger Fellowship from the Austrian Science Foundation (FWF). M.A.M. is supported by a Career Investigator Award from the Michael Smith Foundation for Health Research. We are grateful for the support of the British Columbia Cancer Agency, the British Columbia Cancer Foundation, and the Chan Sisters Foundation. We thank all the staff of the Canada s Michael Smith Genome Sciences Centre for their interest and enthusiasm. 

Jiang Z, Akey JM, Shi J, Xiong M, Wang Y, Shen Y, Xu X, Chen H, Wu H, Xiao J, Lu D, Huang W, Jin L. A polymorphism in the promoter region of catalase is associated with blood pressure levels. Hum Genet 2001 109(l) 95-98. 

Waldron-Lynch F, Adams C, Amos C, Zhu DK, McDermott MF, Shanahan F, Molloy MG, O Gara F. Tumour necrosis factor 5 promoter single nucleotide polymorphisms influence susceptibility to rheumatoid arthritis (RA) in immu-nogenetically defined multiplex RA families. Genes Immun 2001 2(2) 82-87. 

---